Company profile · Basel, Switzerland

Celonic

CDMO, Biologics Manufacturing, Cell Line Development, Process Development, and GMP Production · Commercial and development-stage biologics platform

Verified 22 Mar 2026 · 2 sources

CDMOBiologicsCommercial

Celonic runs biologics manufacturing, cell line development, and process development services in Basel, Switzerland.

Lead
Samanta Cimitan (verified ↗)
Compliance
GMP biologics platform claim
Last reviewed
22 Mar 2026 (2mo ago)
Scale
Commercial and development-stage biologics platform
Capabilities
Biologics Manufacturing · Cell Line Development · Process Development Services
Founded
2007
Headcount
201-500
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Samanta Cimitan

Chief Executive Officer

Check official leadership source
Full addressEisengasse 25, 4051 Basel, Switzerland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official Celonic contact page listing the Basel address.

Open source
Operating profile

Commercial and development-stage biologics platform

Basel, Switzerland. CDMO, Biologics Manufacturing, Cell Line Development, Process Development, and GMP Production. Review completed on 22 Mar 2026.

2026 technical specializationCDMO, Biologics Manufacturing, Cell Line Development, Process Development, and GMP Production
Core capabilities
Biologics ManufacturingCell Line DevelopmentProcess Development Services
Governance

Swissmedic and EU biopharmaceutical manufacturing oversight

Official leadership disclosure, Official Basel address disclosure, GMP biologics platform claim

Editorial note

CDMO, Biologics Manufacturing, Cell Line Development, Process Development, and GMP Production

Celonic is published because official company materials confirm current leadership, Basel operating address, and a real Swiss biologics-manufacturing platform.

Editorial note

Celonic is published because official company materials confirm current leadership, Basel operating address, and a real Swiss biologics-manufacturing platform.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 22 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Biologics Manufacturing
Cell Line Development
Process Development Services
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceOfficial Celonic site naming Samanta Cimitan as CEO.Source origin: celonic.comOpen source
Supporting evidenceOfficial Celonic contact page confirming the Basel address.Source origin: celonic.comOpen source
Physical-site evidenceOfficial Celonic contact page listing the Basel address.Source origin: celonic.comOpen source
Infrastructure

Declared infrastructure

Cell-line development systems
Bioprocess manufacturing infrastructure
Analytical and quality systems
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
VERIFIED ACTIVE 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Celonic located?
Celonic operates from Eisengasse 25, 4051 Basel, Switzerland, Basel, Switzerland.
Who runs Celonic?
Celonic is led by Samanta Cimitan, Chief Executive Officer. Verified 22 Mar 2026.
What certifications does Celonic hold?
Celonic is documented under GMP biologics platform claim.
What does Celonic do?
Celonic runs biologics manufacturing, cell line development, and process development services in Basel, Switzerland. Core capabilities: Biologics Manufacturing, Cell Line Development, Process Development Services.
Editorial context

Related technical briefs

Briefs that name Basel as a covered market or city.